These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 16286056)
1. Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population. Gravenstein S; Drinka P; Osterweil D; Schilling M; Krause P; Elliott M; Shult P; Ambrozaitis A; Kandel R; Binder E; Hammond J; McElhaney J; Flack N; Daly J; Keene O J Am Med Dir Assoc; 2005; 6(6):359-66. PubMed ID: 16286056 [TBL] [Abstract][Full Text] [Related]
2. Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population. Ambrozaitis A; Gravenstein S; van Essen GA; Rubinstein E; Balciuniene L; Stikleryte A; Crawford C; Elliott M; Shult P J Am Med Dir Assoc; 2005; 6(6):367-74. PubMed ID: 16286057 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial. LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541 [TBL] [Abstract][Full Text] [Related]
4. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. Hayden FG; Gubareva LV; Monto AS; Klein TC; Elliot MJ; Hammond JM; Sharp SJ; Ossi MJ; N Engl J Med; 2000 Nov; 343(18):1282-9. PubMed ID: 11058672 [TBL] [Abstract][Full Text] [Related]
5. Antiviral therapy and prophylaxis for influenza in children. American Academy of Pediatrics Committee on Infectious Diseases Pediatrics; 2007 Apr; 119(4):852-60. PubMed ID: 17403862 [TBL] [Abstract][Full Text] [Related]
6. Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home. Lee C; Loeb M; Phillips A; Nesbitt J; Smith K; Fearon M; McArthur MA; Mazzulli T; Li Y; McGeer A Infect Control Hosp Epidemiol; 2000 Nov; 21(11):700-4. PubMed ID: 11089653 [TBL] [Abstract][Full Text] [Related]
7. Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing care population. Hirji Z; O'Grady S; Bonham J; Mak M; Takata-Shewchuk J; Hawkins K; Gardam M; Law L; Mazzulli T; Conly J Infect Control Hosp Epidemiol; 2002 Oct; 23(10):604-8. PubMed ID: 12400891 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza. Ison MG; Gnann JW; Nagy-Agren S; Treannor J; Paya C; Steigbigel R; Elliott M; Weiss HL; Hayden FG; Antivir Ther; 2003 Jun; 8(3):183-90. PubMed ID: 12924534 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks. Schilling M; Povinelli L; Krause P; Gravenstein M; Ambrozaitis A; Jones HH; Drinka P; Shult P; Powers D; Gravenstein S Vaccine; 1998 Nov; 16(18):1771-4. PubMed ID: 9778755 [TBL] [Abstract][Full Text] [Related]
10. Experience with oseltamivir in the control of a nursing home influenza B outbreak. Parker R; Loewen N; Skowronski D Can Commun Dis Rep; 2001 Mar; 27(5):37-40. PubMed ID: 11260987 [TBL] [Abstract][Full Text] [Related]
11. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114 [TBL] [Abstract][Full Text] [Related]
12. Influenza vaccination and antiviral therapy: is there a role for concurrent administration in the institutionalised elderly? Drinka PJ Drugs Aging; 2003; 20(3):165-74. PubMed ID: 12578397 [TBL] [Abstract][Full Text] [Related]
13. Using antiviral agents to control outbreaks of influenza A infection. Monto AS Geriatrics; 1994 Dec; 49(12):30-4. PubMed ID: 7982583 [TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. Mäkelä MJ; Pauksens K; Rostila T; Fleming DM; Man CY; Keene ON; Webster A J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110 [TBL] [Abstract][Full Text] [Related]
15. Effect of timing of amantadine chemoprophylaxis on severity of outbreaks of influenza a in adult long-term care facilities. Rubin MS; Nivin B; Ackelsberg J Clin Infect Dis; 2008 Jul; 47(1):47-52. PubMed ID: 18484879 [TBL] [Abstract][Full Text] [Related]
16. Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks. Anekthananon T; Pukrittayakamee S; Ratanasuwan W; Jittamala P; Werarak P; Charunwatthana P; Suwanagool S; Lawpoolsri S; Stepniewska K; Sapchookul P; Puthavathana P; Fukuda C; Lindegardh N; Tarning J; White NJ; Day N; Taylor WR J Antimicrob Chemother; 2013 Mar; 68(3):697-707. PubMed ID: 23143901 [TBL] [Abstract][Full Text] [Related]
17. Emergence of rimantadine-resistant virus within 6 days of starting rimantadine prophylaxis with oseltamivir treatment of symptomatic cases. Drinka PJ; Haupt T J Am Geriatr Soc; 2007 Jun; 55(6):923-6. PubMed ID: 17537095 [TBL] [Abstract][Full Text] [Related]
18. Detection and control of influenza outbreaks in well-vaccinated nursing home populations. Monto AS; Rotthoff J; Teich E; Herlocher ML; Truscon R; Yen HL; Elias S; Ohmit SE Clin Infect Dis; 2004 Aug; 39(4):459-64. PubMed ID: 15356805 [TBL] [Abstract][Full Text] [Related]
19. Amantadine and rimantadine for the prevention of influenza A. Betts RF Semin Respir Infect; 1989 Dec; 4(4):304-10. PubMed ID: 2697053 [TBL] [Abstract][Full Text] [Related]
20. Outbreaks of influenza A and B in a highly immunized nursing home population. Drinka PJ; Gravenstein S; Krause P; Schilling M; Miller BA; Shult P J Fam Pract; 1997 Dec; 45(6):509-14. PubMed ID: 9420587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]